Related references
Note: Only part of the references are listed.Treatment and Prevention of Heparin-Induced Thrombocytopenia Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Lori-Ann Linkins et al.
CHEST (2012)
Application, tolerance and safety of fondaparinux therapy in a German hospital: A prospective single-centre experience
Marc Schindewolf et al.
THROMBOSIS RESEARCH (2012)
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
Hude Quan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series
T. E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
A Tutorial and Case Study in Propensity Score Analysis: An Application to Estimating the Effect of In-Hospital Smoking Cessation Counseling on Mortality
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Fondaparinux for the Treatment of Acute Heparin-Induced Thrombocytopenia: A Single-Center Experience
Elisavet Grouzi et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2010)
The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion
A. Cuker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia
C. Pouplard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Variable selection for propensity score models
M. Alan Brookhart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings
GK Lo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update
Andreas Greinacher et al.
THROMBOSIS RESEARCH (2006)
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin
TE Warkentin et al.
BLOOD (2005)
Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia
TH Kiser et al.
PHARMACOTHERAPY (2005)
A comparison of lepirudin and argatroban outcomes
MA Smythe et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2005)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin
P Savi et al.
BLOOD (2005)
Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies
N Lubenow et al.
BLOOD (2004)
Intermittent hirudin versus continuous heparin for anticoagulation in continuous renal replacement therapy
OV Hein et al.
RENAL FAILURE (2004)
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia
BE Lewis et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatmeny of acute venous thromboembolism - A randomized, double-blind, controlled trial
MJ Kovacs et al.
ANNALS OF INTERNAL MEDICINE (2003)
Heparin-induced thrombocytopenia:: Pathophysiology and new treatment options
J Harenberg et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody
ZQ Li et al.
BLOOD (2002)